MilliporeSigma
  • Signatures of cell stress and altered bioenergetics in skin fibroblasts from patients with multiple sclerosis.

Signatures of cell stress and altered bioenergetics in skin fibroblasts from patients with multiple sclerosis.

Aging (2020-07-09)
Jordan M Wilkins, Oleksandr Gakh, Parijat Kabiraj, Christina B McCarthy, W Oliver Tobin, Charles L Howe, Claudia F Lucchinetti
ABSTRACT

Multiple sclerosis (MS) is a central nervous system inflammatory demyelinating disease and the most common cause of non-traumatic disability in young adults. Despite progress in the treatment of the active relapsing disease, therapeutic options targeting irreversible progressive decline remain limited. Studies using skin fibroblasts derived from patients with neurodegenerative disorders demonstrate that cell stress pathways and bioenergetics are altered when compared to healthy individuals. However, findings in MS skin fibroblasts are limited. Here, we collected skin fibroblasts from 24 healthy control individuals, 30 patients with MS, and ten with amyotrophic lateral sclerosis (ALS) to investigate altered cell stress profiles. We observed endoplasmic reticulum swelling in MS skin fibroblasts, and increased gene expression of cell stress markers including BIP, ATF4, CHOP, GRP94, P53, and P21. When challenged against hydrogen peroxide, MS skin fibroblasts had reduced resiliency compared to ALS and controls. Mitochondrial and glycolytic functions were perturbed in MS skin fibroblasts while exhibiting a significant increase in lactate production over ALS and controls. Our results suggest that MS skin fibroblasts have an underlying stress phenotype, which may be disease specific. Interrogating MS skin fibroblasts may provide patient specific molecular insights and aid in prognosis, diagnosis, and therapeutic testing enhancing individualized medicine.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
(±)-3-Methyl-2-oxovaleric acid sodium salt
Sigma-Aldrich
Carbonyl cyanide 4-(trifluoromethoxy)phenylhydrazone, ≥98% (TLC), powder
Sigma-Aldrich
4-Methyl-2-oxovaleric acid, ≥98.0% (T)
Sigma-Aldrich
3-Hydroxybutyric acid, 95%
Sigma-Aldrich
3-Methyl-13C-glutaconic acid-2,4-13C2, cis/trans mixture, 99 atom % 13C, ≥98% (CP)
Sigma-Aldrich
α-Ketoglutaric acid, ≥98.5% (NaOH, titration)
Sigma-Aldrich
2-Deoxy-D-glucose, ≥98% (GC), crystalline
Sigma-Aldrich
2-Ketobutyric acid, 97%
Sigma-Aldrich
2-Hydroxybutanoic acid, AldrichCPR
Supelco
3-Methylglutaconic acid, mixture of E and Z isomers, ≥98.0% (HPLC)
Sigma-Aldrich
Sodium DL-3-hydroxybutyrate-1,3-13C2, 99 atom % 13C
Sigma-Aldrich
3-Methyl-2-oxopentanoic acid, AldrichCPR
Sigma-Aldrich
Antimycin A from Streptomyces sp.
Sigma-Aldrich
Lithium acetoacetate, ≥90% (HPLC)
Sigma-Aldrich
Citric acid, 99%
Sigma-Aldrich
Sodium DL-lactate, ReagentPlus®, ≥99.0% (NT)
Sigma-Aldrich
Sodium pyruvate-13C3, 99 atom % 13C
Sigma-Aldrich
β-Hydroxyisovaleric acid, ≥95.0% (T)
Sigma-Aldrich
Fumaric acid, ≥99.0% (T)
Sigma-Aldrich
Thiazolyl Blue Tetrazolium Bromide, 98%
Sigma-Aldrich
Fetal Bovine Serum, USA origin, sterile-filtered, suitable for cell culture, suitable for hybridoma
Sigma-Aldrich
Succinic acid, BioXtra, BioRenewable, ≥99.0%
Sigma-Aldrich
Sodium 3-methyl-2-oxobutyrate, 95%
Sigma-Aldrich
Pyruvic acid, 98%
Sigma-Aldrich
DL-Malic acid, ReagentPlus®, ≥99%